Search results for "PANCREATITIS"

showing 10 items of 173 documents

Plasma calprotectin assay in patients with acute pancreatitis

2003

CalprotectinSettore MED/09 - Medicina Internaacute pancreatitis
researchProduct

Rapid progression of a splenic aneurysm due to segmental arterial mediolysis: a rare cause of acute pancreatitis.

2013

Abstract Background The etiology of acute pancreatitis can be manifold, beside the usual causes. We are reporting an unusual cause that triggered acute pancreatitis. Patient & results A 50 year-old male experienced attacks of acute pancreatitis (abdominal pain and elevated amylase and lipase) during sexual arousal. Serial imaging showed a rapidly-progressing, partly-thrombosed splenic artery aneurysm, with local compression of the pancreas. After angiographic coiling, the attacks subsided. Further angiography revealed additional aneurysms consistent with segmental arterial mediolysis at other sites of the body. Molecular analysis regarding Ehlers–Danlos-syndrome and genetic factors for panc…

MaleAbdominal painmedicine.medical_specialtyEndocrinology Diabetes and MetabolismMedizinBlood PressureAneurysm RupturedRadiology InterventionalAneurysmInternal medicinemedicineHumansSexual Dysfunctions PsychologicalHepatologymedicine.diagnostic_testbusiness.industryGastroenterologymedicine.diseaseAneurysmAbdominal PainRadiographymedicine.anatomical_structureBlood pressurePancreatitisAngiographyCardiologyEtiologyAcute pancreatitisPancreatitisRadiologymedicine.symptombusinessPancreasSplenic ArteryPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
researchProduct

Traitement de la pancréatite chronique. L’expérience allemande. Le point de vue de l’endoscopiste

1999

medicine.medical_specialtyPancreatic diseasemedicine.diagnostic_testbusiness.industryGeneral surgerymedicine.medical_treatmentEndoscopic surgeryStentInterventional radiologymedicine.diseaseEndoscopymedicinePancreatitisRadiology Nuclear Medicine and imagingbusinessAbdominal surgeryActa Endoscopica
researchProduct

Adverse drug reactions to antiretroviral medication

2009

Antiretroviral therapy has greatly improved prognosis of HIV infection, with a dramatic reduction of morbidity and mortality worldwide. Nevertheless, the condition is still a common cause of death in many underdeveloped countries, where effective treatment is not always unavailable. More than 20 drugs active against HIV are commercially available, which belong to one of four groups: nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, and fusion/entry inhibitors. In the near future new drugs are expected, including those of a novel group, the integrase inhibitors. To avoid viral resistance, combinations of the drugs must always b…

LipodystrophyAnti-HIV Agentsmedicine.medical_treatmentIntegrase inhibitorHIV InfectionsBioinformaticsCardiovascular SystemNervous SystemNucleoside Reverse Transcriptase InhibitorDrug HypersensitivityBone MarrowHumansMedicineEffective treatmentLactic AcidDrug reactionUrinary TractAdverse effectProteasebusiness.industryOsteonecrosisReverse transcriptaseGastrointestinal TractBone Diseases MetabolicLiverPancreatitisAntiretroviral medicationbusinessFrontiers in Bioscience
researchProduct

Post-ERCP pancreatitis: A single center experience and an update on prevention strategies

2015

Pancreatitis is the most frequent complication of the ERCP; in unselected patients the incidence is 3.5%, reaching 25%, and is mild-moderate in 90%. A stratification of patients into low or high risk is important to provide adequate information to patients and to decide when refer them to tertiary centers; moreover, many prophylactic measures have been proposed over years. Our aim was to select risk factors for PEP and compare them with current literature in order to propose adequate preventive strategies.It was analyzed the occurrence of Post-ERCP Pancreatitis in a series of 492 consecutives patients treated with ERCP by two expert interventional endoscopists. The possible risk factors wer…

Cholangiopancreatography Endoscopic RetrogradeSettore MED/18 - Chirurgia GeneralePancreatitisRisk FactorsEndoscopic retrograde cholangiopancreatography PancreatitisMultivariate AnalysisContrast MediaHumansCatheterization
researchProduct

5-Aminosalicylsäure-assoziierte Pankreatitis

2008

Acute pancreatitis with severe belt-like upper abdominal pain developed within 1-4 weeks of starting medication in three patients (29-year-old man with ulcerative colitis; 43-year-old woman and 22-year-old woman with Crohn's disease) treated, for the first time, with 5-aminosalicylic acid (mesalazine), 500 mg three times daily. Concentrations of lipase initially were 545, 1182 and 3000 U/l, and of amylase 243, 449 and 129 U/l, respectively. Symptoms receded within a few hours after the drug had been discontinued, enzyme levels returning to normal in the course of the next 2-3 weeks. On repeating the drug in two of the patients, in lower dosage, the pancreatitis recurred within a few days. T…

Drugmedicine.medical_specialtybiologybusiness.industrymedia_common.quotation_subjectGeneral Medicinemedicine.diseaseGastroenterologyUlcerative colitischemistry.chemical_compoundMesalazinechemistryInternal medicineUpper abdominal painbiology.proteinMedicinePancreatitisAcute pancreatitisAmylaseLipasebusinessmedia_commonDMW - Deutsche Medizinische Wochenschrift
researchProduct

The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes

2020

ABSTRACT Introduction The dipeptidyl peptidase-4 inhibitors (DPP-4is), which belong to the class of incretin-based medications, are recommended as second or third-line therapies in guidelines for the management of type 2 diabetes mellitus. They have a favorable drug tolerability and safety profile compared to other glucose-lowering agents. Objective This review discusses data concerning the use of DPP-4is and their cardiovascular profile, and gives an updated comparison with the other oral glucose-lowering medications with regards to safety and efficacy. Currently available original studies, abstracts, reviews articles, systematic reviews and meta-analyses were included in the review. Discu…

0301 basic medicinemedicine.medical_specialtyEndocrinology Diabetes and MetabolismIncretin030209 endocrinology & metabolismType 2 diabetesSaxagliptinLinagliptinIncretins03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInternal medicinemedicineHumansHypoglycemic AgentsVildagliptinDipeptidyl-Peptidase IV InhibitorsPancreatitiHypoglycemic Agentbusiness.industryPancreatic NeoplasmIncretinmedicine.diseasePancreatic NeoplasmsTreatment Outcome030104 developmental biologyDiabetes Mellitus Type 2PancreatitischemistryTolerabilitySitagliptinDipeptidyl-Peptidase IV InhibitorbusinessAlogliptinHumanmedicine.drugMetabolism
researchProduct

Inflammatory and tumor-like lesions of the pancreas

2020

Summary Inflammatory/tumor-like lesions of the pancreas represent a heterogeneous group of diseases that can variably involve the pancreatic gland determining different signs and symptoms. In the category of inflammatory/tumor-like lesions of the pancreas, the most important entities are represented by chronic pancreatitis, which includes alcoholic, obstructive and hereditary pancreatitis, paraduodenal (groove) pancreatitis, autoimmune pancreatitis, lymphoepithelial cyst, pancreatic hamartoma and intrapancreatic accessory spleen. An in-depth knowledge of such diseases is essential, since they can cause severe morbidity and may represent a potential life-threatening risk for patients. Furthe…

Pathologymedicine.medical_specialtyautoimmune pancreatitiReviewSettore MED/08 - Anatomia PatologicaAccessory spleenparaduodenal pancreatitisPathology and Forensic MedicineDiagnosis Differentialchronic pancreatitisPancreatitis Chronicparaduodenal pancreatitis.groovemedicineHamartomaPancreasAutoimmune pancreatitisHereditary pancreatitisbusiness.industrymedicine.diseaseautoimmune pancreatitisPancreatic Neoplasmspancreatic pathologymedicine.anatomical_structurePancreatitisSevere morbidityPancreatitischronic pancreatitiDifferential diagnosisPancreasbusinessautoimmune pancreatitis; chronic pancreatitis; groove; pancreatic pathology; paraduodenal pancreatitis
researchProduct

Haemoglobin in ascitic fluid increases lipid peroxidation in acute pancreatitis

2012

Ascitic fluidmedicine.medical_specialtybusiness.industrymedicine.diseaseBiochemistryGastroenterologyLipid peroxidationchemistry.chemical_compoundchemistryBiochemistryPhysiology (medical)Internal medicinemedicineAcute pancreatitisbusinessFree Radical Biology and Medicine
researchProduct

The Spanish Pancreatic Club's recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment).

2012

Chronic pancreatitis (CP) is a complex disease with a wide range of clinical manifestations. This range comprises from asymptomatic patients to patients with disabling symptoms or complications. The management of CP is frequently different between geographic areas and even medical centers. This is due to the paucity of high quality studies and clinical practice guidelines regarding its diagnosis and treatment. The aim of the Spanish Pancreatic Club was to give current evidence-based recommendations for the management of CP. Two coordinators chose a multidisciplinary panel of 24 experts on this disease. These experts were selected according to clinical and research experience in CP. A list o…

medicine.medical_specialtyPancreatic pseudocystEndocrinology Diabetes and MetabolismExocrine pancreatic insufficiencyMEDLINENutritional StatusDiseaseConstriction PathologicGuidelinesPancreatitis ChronicPancreatic PseudocystDiagnosismedicinePain ManagementPancreatitis chronicIntensive care medicineExocrine pancreatic insufficiencyAcetaminophenCholangiopancreatography Endoscopic RetrogradeEvidence-Based MedicineHepatologybusiness.industryAnti-Inflammatory Agents Non-SteroidalGastroenterologyEvidence-based medicinemedicine.diseaseSurgeryPancreatic fistulaPancreatitisDrainageExocrine Pancreatic InsufficiencyTherapybusiness
researchProduct